China has said that some vaccines for the novel coronavirus could be in clinical use next month as the number of global coronavirus cases soared past 100,000.  Zheng Zhongwei, director of the National Health Commission’s Science and Technology Development Center, expressed his hope of the vaccines would enter clinical research or be of use in emergency situation in April.

Researchers at the Miguel Institute, supported by the Ministry of Science and Technology, explain the research at a press conference. They claim the vaccine’s efficacy has been proven in preclinical trials, and that the virus in poultry has a high genetic identity to the human virus and can be adapted within three months for human testing.